Phosphate Is a Uremic Toxin

Journal of Renal Nutrition

Volumn 18, Issue 1, 2008, Pages 27-32

  Burke, Steven K ^a  

^a Proteon Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATE;

ARTICLE; BLOOD; BONE DISEASE; CALCINOSIS; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; DIET; DRUG EFFECT; HUMAN; HYPERPHOSPHATEMIA; HYPERTHYROIDISM; HYPOKALEMIA; INTESTINE ABSORPTION; KIDNEY; KIDNEY DISEASE; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSIOLOGY; VASCULAR DISEASE;

ARTERIAL OCCLUSIVE DISEASES; BONE DISEASES; CALCINOSIS; DIET; HUMANS; HYPERPHOSPHATEMIA; HYPERTHYROIDISM; HYPOKALEMIA; INTESTINAL ABSORPTION; KIDNEY; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; PHOSPHATES; VASCULAR DISEASES;

EID: 37049013062     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2007.10.007     Document Type: Article

References (63)

1. Schaefer K. Alternative phosphate binders: an update. Nephrol Dial Transplant 8 Suppl 1 (1993) 35-39
2. Delmez J.A., and Slatopolsky E. Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis 19 (1992) 303-317
3. Liu S., and Quarles L.D. How fibroblast growth factor 23 works. J Am Soc Nephrol 18 (2007) 1637-1647
4. Amanzadeh J., and Reilly Jr. R.F. Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol 2 (2006) 136-148
5. Brunelli S.M., and Goldfarb S. Hypophosphatemia: clinical consequences and management. J Am Soc Nephrol 18 (2007) 1999-2003
6. Gaasbeek A., and Meinders A.E. Hypophosphatemia: an update on its etiology and treatment. Am J Med 118 (2005) 1094-1101
7. Slatopolsky E., and Bricker N.S. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney Int 4 (1973) 141-145
8. Slatopolsky E., Caglar S., Gradowska L., et al. On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using "proportional reduction" of dietary phosphorus intake. Kidney Int 2 (1972) 147-151
9. Cozzolino M., Dusso A.S., Liapis H., et al. The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats. J Am Soc Nephrol 13 (2002) 2299-2308
10. Cozzolino M., Staniforth M.E., Liapis H., et al. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Kidney Int 64 (2003) 1653-1661
11. Katsumata K., Kusano K., Hirata M., et al. Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. Kidney Int 64 (2003) 441-450
12. Portale A.A., Booth B.E., Halloran B.P., et al. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 73 (1984) 1580-1589
13. Lopez-Hilker S., Dusso A.S., Rapp N.S., et al. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J Physiol 259 (1990) F432-F437
14. Slatopolsky E., and Delmez J.A. Pathogenesis of secondary hyperparathyroidism. Nephrol Dial Transplant 11 Suppl 3 (1996) 130-135
15. Silver J., Kilav R., and Naveh-Many T. Mechanisms of secondary hyperparathyroidism. Am J Physiol Renal Physiol 283 (2002) F367-F376
16. Slatopolsky E., Brown A., and Dusso A. Calcium, phosphorus and vitamin D disorders in uremia. Contrib Nephrol 149 (2005) 261-271
17. Craver L., Marco M.P., Martinez I., et al. Mineral metabolism parameters throughout chronic kidney disease stages 1-5-achievement of K/DOQI target ranges. Nephrol Dial Transplant 22 (2007) 1171-1176
18. Levin A., Bakris G.L., Molitch M., et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71 (2007) 31-38
19. Combe C., and Aparicio M. Phosphorus and protein restriction and parathyroid function in chronic renal failure. Kidney Int 46 (1994) 1381-1386
20. Combe C., Morel D., de Precigout V., et al. Long-term control of hyperparathyroidism in advanced renal failure by low-phosphorus low-protein diet supplemented with calcium (without changes in plasma calcitriol). Nephron 70 (1995) 287-295
21. Llach F., Keshav G., Goldblat M.V., et al. Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2. Am J Kidney Dis 32 Suppl (1998) S48-S54
22. Aparicio M., Combe C., Lafage M.H., et al. In advanced renal failure, dietary phosphorus restriction reverses hyperparathyroidism independent of changes in the levels of calcitriol. Nephron 63 (1993) 122-123
23. Tessitore N., Venturi A., Adami S., et al. Relationship between serum vitamin D metabolites and dietary intake of phosphate in patients with early renal failure. Miner Electrolyte Metab 13 (1987) 38-44
24. Slatopolsky E., Finch J., Denda M., et al. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97 (1996) 2534-2540
25. Llach F., and Massry S.G. On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency. J Clin Endocrinol Metab 61 (1985) 601-606
26. Sheikh M.S., Ramirez A., Emmett M., et al. Role of vitamin D-dependent and vitamin D-independent mechanisms in absorption of food calcium. J Clin Invest 81 (1988) 126-132
27. Delmez J.A., Tindira C., Grooms P., et al. Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium. J Clin Invest 83 (1989) 1349-1355
28. Rodriguez M., Martin-Malo A., Martinez M.E., et al. Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol. Kidney Int 40 (1991) 1055-1062
29. Andress D.L., Endres D.B., Maloney N.A., et al. Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy. J Clin Endocrinol Metab 63 (1986) 1163-1169
30. Malluche H.H., Ritz E., Lange H.P., et al. Bone histology in incipient and advanced renal failure. Kidney Int 9 (1976) 355-362
31. Block G.A., Klassen P.S., Lazarus J.M., et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15 (2004) 2208-2218
32. Sherrard D.J., Hercz G., Pei Y., et al. The spectrum of bone disease in end-stage renal failure-an evolving disorder. Kidney Int 43 (1993) 436-442
33. Parfitt A.M. Soft-tissue calcification in uremia. Arch Intern Med 124 (1969) 544-556
34. Braun J., Oldendorf M., Moshage W., et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27 (1996) 394-401
35. Raggi P., Boulay A., Chasan-Taber S., et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?. J Am Coll Cardiol 39 (2002) 695-701
36. Russo D., Palmiero G., De Blasio A.P., et al. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 44 (2004) 1024-1030
37. Goodman W.G., Goldin J., Kuizon B.D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342 (2000) 1478-1483
38. Chertow G.M., Raggi P., Chasan-Taber S., et al. Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 19 (2004) 1489-1496
39. London G.M., Guerin A.P., Marchais S.J., et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18 (2003) 1731-1740
40. Block G.A., Spiegel D.M., Ehrlich J., et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68 (2005) 1815-1824
41. Braun J., Asmus H.G., Holzer H., et al. Long-term comparison of a calcium-free phosphate binder and calcium carbonate-phosphorus metabolism and cardiovascular calcification. Clin Nephrol 62 (2004) 104-115
42. Chertow G.M., Dillon M., Burke S.K., et al. A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients. Clin Nephrol 51 (1999) 18-26
43. Giachelli C.M., Jono S., Shioi A., et al. Vascular calcification and inorganic phosphate. Am J Kidney Dis 38 Suppl (2001) S34-S37
44. Steitz S.A., Speer M.Y., Curinga G., et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 89 (2001) 1147-1154
45. Yang H., Curinga G., and Giachelli C.M. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int 66 (2004) 2293-2299
46. Reynolds J.L., Joannides A.J., Skepper J.N., et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15 (2004) 2857-2867
47. Ketteler M. Fetuin-A and extraosseous calcification in uremia. Curr Opin Nephrol Hypertens 14 (2005) 337-342
48. Ketteler M., Wanner C., Metzger T., et al. Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia. Kidney Int 63 Suppl (2003) S84-S87
49. London G.M., Marchais S.J., Guerin A.P., et al. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens 14 (2005) 525-531
50. Blacher J., Guerin A.P., Pannier B., et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38 (2001) 938-942
51. Guerin A.P., London G.M., Marchais S.J., et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15 (2000) 1014-1021
52. Block G.A., Raggi P., Bellasi A., et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 71 (2007) 438-441
53. Raggi P., Bellasi A., Ferramosca E., et al. Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int 71 (2007) 802-807
54. Adragao T., Pires A., Lucas C., et al. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 19 (2004) 1480-1488
55. Young E.W., Akiba T., Albert J.M., et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 44 (2004) 34-38
56. Teng M., Wolf M., Lowrie E., et al. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349 (2003) 446-456
57. Melamed M.L., Eustace J.A., Plantinga L., et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 70 (2006) 351-357
58. Block G.A., Hulbert-Shearon T.E., Levin N.W., et al. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31 (1998) 607-617
59. Blacher J., Guerin A.P., Pannier B., et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99 (1999) 2434-2439
60. Kaysen G.A., Muller H.G., Young B.S., et al. The influence of patient- and facility-specific factors on nutritional status and survival in hemodialysis. J Ren Nutr 14 (2004) 72-81
61. Leypoldt J.K. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration. Semin Dial 18 (2005) 401-408
62. Chertow G.M., Burke S.K., and Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62 (2002) 245-252
63. Suki W.N., Zabaneh R., Cangiano J.L., et al. Effects of sevelamer and calcium-based phosphate binder on mortality in hemodialysis patients. Kidney Int 72 (2007) 1130-1137